Official recall notice

FDA DrugClass INotable

FDA Recall: Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous

Recall date
2026-09-16
Category
Drug
FDA class
Class I

Why it was recalled

Hazard

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Product description

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Affected products

Lots: 25128L1C0, Exp. August 31, 2026; 25280L1C0, Exp. October 31, 2026; 26108L1C0, Exp. July 31, 2027

Verify with the official notice →
Share:

Related Recalls

2026-09-03 · FDA_FOOD
FDA Recall: American Regent, Inc.: Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial
American Regent, Inc.
2026-08-26 · FDA_DRUG
FDA Recall: Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-D
American Regent, Inc.
2026-08-26 · FDA_DRUG
FDA Recall: ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-
American Regent, Inc.
2026-08-26 · FDA_DRUG
FDA Recall: ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-
American Regent, Inc.